Cholesterol Sulfate and Cholesterol Sulfotransferase Inhibit Gluconeogenesis by Targeting Hepatocyte Nuclear Factor 4α

REFERENCES

• Strott CA. 2002. Sulfonation and molecular action. Endocr. Rev. 23:703–732. http://dx.doi.org/10.1210/er.2001-0040.
   PubMed Web of Science ®Google Scholar
• Gong HB, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, Song WC, Cheng SY, Xie W. 2007. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol. Endocrinol. 21:1781–1790. http://dx.doi.org/10.1210/me.2007-0187.
   PubMed Web of Science ®Google Scholar
• Lee JH, Gong H, Khadem S, Lu Y, Gao X, Li S, Zhang J, Xie W. 2008. Androgen deprivation by activating the liver X receptor. Endocrinology 149:3778–3788. http://dx.doi.org/10.1210/en.2007-1605.
   PubMed Web of Science ®Google Scholar
• Zhang B, Cheng QQ, Ou ZM, Lee JH, Xu MS, Kochhar U, Ren SR, Huang M, Pflug BR, Xie W. 2010. Pregnane X receptor as a therapeutic target to inhibit androgen activity. Endocrinology 151:5721–5729. http://dx.doi.org/10.1210/en.2010-0708.
   PubMed Web of Science ®Google Scholar
• Visser TJ. 1994. Role of sulfation in thyroid hormone metabolism. Chem. Biol. Interact. 92:293–303. http://dx.doi.org/10.1016/0009-2797(94)90071-X.
   PubMed Web of Science ®Google Scholar
• Saini SPS, Sonoda J, Xu L, Toma D, Uppal H, Mu Y, Ren SR, Moore DD, Evans RM, Xie W. 2004. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol. Pharmacol. 65:292–300. http://dx.doi.org/10.1124/mol.65.2.292.
   PubMed Web of Science ®Google Scholar
• Bai Q, Zhang X, Xu L, Kakiyama G, Heuman D, Sanyal A, Pandak WM, Yin L, Xie W, Ren S. 2012. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. Metabolism 61:836–845. http://dx.doi.org/10.1016/j.metabol.2011.11.014.
   PubMed Web of Science ®Google Scholar
• Javitt NB, Lee YC, Shimizu C, Fuda H, Strott CA. 2001. Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology 142:2978–2984. http://dx.doi.org/10.1210/en.142.7.2978.
   PubMed Web of Science ®Google Scholar
• Shimizu C, Fuda H, Yanai H, Strott CA. 2003. Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1. Endocrinology 144:1186–1193. http://dx.doi.org/10.1210/en.2002-221011.
   PubMed Web of Science ®Google Scholar
• Fuda H, Javitt NB, Mitamura K, Ikegawa S, Strott CA. 2007. Oxysterols are substrates for cholesterol sulfotransferase. J. Lipid Res. 48:1343–1352. http://dx.doi.org/10.1194/jlr.M700018-JLR200.
   PubMed Web of Science ®Google Scholar
• Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou HP, Maher J, Kellum J, Warnick R, Contos MJ, Sanyal AJ. 2012. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15:665–674. http://dx.doi.org/10.1016/j.cmet.2012.04.004.
   PubMed Web of Science ®Google Scholar
• Strott CA, Higashi Y. 2003. Cholesterol sulfate in human physiology: what's it all about? J. Lipid Res. 44:1268–1278. http://dx.doi.org/10.1194/jlr.R300005-JLR200.
   PubMed Web of Science ®Google Scholar
• Dong B, Saha PK, Huang WD, Chen WL, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD. 2009. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc. Natl. Acad. Sci. U. S. A. 106:18831–18836. http://dx.doi.org/10.1073/pnas.0909731106.
   PubMed Web of Science ®Google Scholar
• Tamasawa N, Tamasawa A, Takebe K. 1993. Higher levels of plasma cholesterol sulfate in patients with liver cirrhosis and hypercholesterolemia. Lipids 28:833–836. http://dx.doi.org/10.1007/BF02536238.
   PubMedGoogle Scholar
• Veares MP, Evershed RP, Prescott MC, Goad LJ. 1990. Quantitative determination of cholesterol sulphate in plasma by stable isotope dilution fast atom bombardment mass spectrometry. Biomed. Environ. Mass Spectrom. 19:583–588. http://dx.doi.org/10.1002/bms.1200191002.
   PubMedGoogle Scholar
• Drayer NM, Lieberman S. 1967. Isolation of cholesterol sulfate from human aortas and adrenal tumors. J. Clin. Endocrinol. Metab. 27:136–139. http://dx.doi.org/10.1210/jcem-27-1-136.
   PubMed Web of Science ®Google Scholar
• Kallen J, Schlaeppi JM, Bitsch F, Delhon I, Fournier B. 2004. Crystal structure of the human RORα ligand binding domain in complex with cholesterol sulfate at 2.2 Å. J. Biol. Chem. 279:14033–14038. http://dx.doi.org/10.1074/jbc.M400302200.
   PubMed Web of Science ®Google Scholar
• Seneff S, Davidson R, Mascitelli L. 2012. Might cholesterol sulfate deficiency contribute to the development of autistic spectrum disorder? Med. Hypotheses 78:213–217. http://dx.doi.org/10.1016/j.mehy.2011.10.026.
   PubMedGoogle Scholar
• Yamamoto K, Miyazaki K, Higashi S. 2010. Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin. J. Biol. Chem. 285:28862–28873. http://dx.doi.org/10.1074/jbc.M110.136994.
   PubMedGoogle Scholar
• Johnson AM, Olefsky JM. 2013. The origins and drivers of insulin resistance. Cell 152:673–684. http://dx.doi.org/10.1016/j.cell.2013.01.041.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. 2004. Pathogenesis of type 2 diabetes mellitus. Med. Clin. North Am. 88:787–835. http://dx.doi.org/10.1016/j.mcna.2004.04.013.
   PubMed Web of Science ®Google Scholar
• DeLaForest A, Nagaoka M, Si-Tayeb K, Noto FK, Konopka G, Battle MA, Duncan SA. 2011. HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development 138:4143–4153. http://dx.doi.org/10.1242/dev.062547.
   PubMed Web of Science ®Google Scholar
• Komatsu K, Driscoll WJ, Koh YC, Strott CA. 1994. A P-loop related motif (GxxGxxK) highly conserved in sulfotransferases is required for binding the activated sulfate donor. Biochem. Biophys. Res. Commun. 204:1178–1185. http://dx.doi.org/10.1006/bbrc.1994.2587.
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Katrakili N, Talianidis I. 2000. Acetylation regulates transcription factor activity at multiple levels. Mol. Cell 5:745–751. http://dx.doi.org/10.1016/S1097-2765(00)80253-1.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhai YG, Mu Y, Gong HB, Uppal H, Toma D, Ren SR, Evans RM, Xie W. 2006. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 281:15013–15020. http://dx.doi.org/10.1074/jbc.M511116200.
   PubMed Web of Science ®Google Scholar
• Song YK, Liu F, Zhang G, Liu D. 2002. Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA. Methods Enzymol. 346:92–105. http://dx.doi.org/10.1016/S0076-6879(02)46050-8.
   PubMed Web of Science ®Google Scholar
• Yin L, Ma H, Ge X, Edwards PA, Zhang Y. 2011. Hepatic hepatocyte nuclear factor 4α is essential for maintaining triglyceride and cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 31:328–336. http://dx.doi.org/10.1161/ATVBAHA.110.217828.
   PubMed Web of Science ®Google Scholar
• Gao J, He J, Shi X, Stefanovic-Racic M, Xu M, O'Doherty RM, Garcia-Ocana A, Xie W. 2012. Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes. Diabetes 61:1543–1551. http://dx.doi.org/10.2337/db11-1152.
   PubMed Web of Science ®Google Scholar
• He J, Hu B, Shi X, Weidert ER, Lu P, Xu M, Huang M, Kelley EE, Xie W. 2013. Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol. Cell. Biol. 33:2047–2055. http://dx.doi.org/10.1128/MCB.01658-12.
   PubMed Web of Science ®Google Scholar
• Wada T, Ihunnah CA, Gao J, Chai X, Zeng S, Philips BJ, Rubin JP, Marra KG, Xie W. 2011. Estrogen sulfotransferase inhibits adipocyte differentiation. Mol. Endocrinol. 25:1612–1623. http://dx.doi.org/10.1210/me.2011-1089.
   PubMedGoogle Scholar
• Wada T, Gao J, Xie W. 2009. PXR and CAR in energy metabolism. Trends Endocrinol. Metab. 20:273–279. http://dx.doi.org/10.1016/j.tem.2009.03.003.
   PubMed Web of Science ®Google Scholar
• Kim DH, Perdomo G, Zhang T, Slusher S, Lee S, Phillips BE, Fan Y, Giannoukakis N, Gramignoli R, Strom S, Ringquist S, Dong HH. 2011. FoxO6 integrates insulin signaling with gluconeogenesis in the liver. Diabetes 60:2763–2774. http://dx.doi.org/10.2337/db11-0548.
   PubMedGoogle Scholar
• Sone H, Shimano H, Sakakura Y, Inoue N, Amemiya-Kudo M, Yahagi N, Osawa M, Suzuki H, Yokoo T, Takahashi A, Iida K, Toyoshima H, Iwama A, Yamada N. 2002. Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am. J. Physiol. Endocrinol. Metab. 282:E222–E230. http://dx.doi.org/10.1152/ajpendo.00189.2001.
   PubMed Web of Science ®Google Scholar
• Reference deleted.
   Google Scholar
• Dietschy JM. 1984. Regulation of cholesterol metabolism in man and in other species. Klin. Wochenschr. 62:338–345. http://dx.doi.org/10.1007/BF01716251.
   PubMedGoogle Scholar
• Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. 2001. Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21:1393–1403. http://dx.doi.org/10.1128/MCB.21.4.1393-1403.2001.
   PubMed Web of Science ®Google Scholar
• Luong A, Hannah VC, Brown MS, Goldstein JL. 2000. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 275:26458–26466. http://dx.doi.org/10.1074/jbc.M004160200.
   PubMedGoogle Scholar
• Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. 2007. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5:73–79. http://dx.doi.org/10.1016/j.cmet.2006.11.012.
   PubMed Web of Science ®Google Scholar
• Xu L, Bai Q, Rodriguez-Agudo D, Hylemon PB, Heuman DM, Pandak WM, Ren S. 2010. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate. Lipids 45:821–832. http://dx.doi.org/10.1007/s11745-010-3451-y.
   PubMed Web of Science ®Google Scholar
• Wada T, Kang HS, Jetten AM, Xie W. 2008. The emerging role of nuclear receptor RORα and its crosstalk with LXR in xeno- and endobiotic gene regulation. Exp. Biol. Med. (Maywood) 233:1191–1201. http://dx.doi.org/10.3181/0802-MR-50.
   PubMedGoogle Scholar
• Delerive P, Monte D, Dubois G, Trottein F, Fruchart-Najib J, Mariani J, Fruchart J-C, Staels B. 2001. The orphan nuclear receptor RORα is a negative regulator of the inflammatory response. EMBO Rep. 2:42–48. http://dx.doi.org/10.1093/embo-reports/kve007.
   PubMed Web of Science ®Google Scholar
• Klok MD, Jakobsdottir S, Drent ML. 2007. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes. Rev. 8:21–34. http://dx.doi.org/10.1111/j.1467-789X.2006.00270.x.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. 2012. Bile acid signaling in liver metabolism and diseases. J. Lipids 2012:754067. http://dx.doi.org/10.1155/2012/754067.
   PubMedGoogle Scholar